Supernus Pharmaceuticals (SUPN) Q3 2017 Earnings

2AugConfirmed
Q3 2016
Q1 2017
Q2 2017
Q3 2017
0.13
0.19
0.26
0.32

Details

Expected EPS
0.24
Actual EPS
0.32
Surprise EPS
0.08
Surprise Percent
+33.33%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.32 per share for Q3 2017.

0 Comments

Share your thoughts